, /PRNewswire/ -- USANA (NYSE:USNA) is proud to announce that its chief scientific officer, Dr. Kathryn Armstrong, has received the Women Tech Award from the Women Tech Council of Utah. Dr. Kathryn Armstrong named a "Leadership Excellence Award" winner Dr. Kathryn Armstrong Dr. Kathryn Armstrong receives the Leadership Excellence Award from the Women in Tech Council The Women Tech Award is a distinguished recognition platform that celebrates women who are significantly contributing to the expansion and inno ...

Company Overview - PetMeds, founded in 1996, has over 11 million customers across the US[14] - PetMeds' strategic initiatives include pet telemedicine through Vetster[16] - The company's vision is for every pet to live a long, happy, healthy life, aiming to be the most trusted pet health expert[12] Financial Performance - In FY 2022, PetMeds' revenue was $273.4 million[17] - Net income for FY 2022 was $21.1 million[17] - Adjusted EBITDA for FY 2022 was $34.0 million[17] - AutoShip & Save subscriptions accounted for 42% of total revenue[17] Market Opportunity and Strategy - The total pet market in 2021 was $123 billion[22] - PetMeds is expanding into holistic health and wellness, including medication, care, wellness, and nutrition[18] - The company is pursuing growth through new customer acquisition, increased recurring subscription revenue, non-medication catalog expansion, and unique services[24]

Group 1 - USANA President and CEO Jim Brown has been elected to the Board of Directors of the Direct Selling Association (DSA) for a three-year term [1] - Jim Brown has over 25 years of leadership experience, with 19 years at USANA in various roles [1] - The DSA has been a national trade association for direct selling companies for over a century, generating $36.7 billion in retail sales in 2023 [2] Group 2 - In 2023, 6.1 million entrepreneurs in the U.S. engaged in direct selling, providing a personalized buying experience for customers [2] - DSA CEO David Grimaldi expressed confidence in Jim Brown's impact on the board, highlighting his significant experience in the industry [3] - USANA has been recognized for its quality nutritional and lifestyle products for over 30 years [4]

Core Insights - USANA has released its fifth annual sustainability report, showcasing its commitment to sustainability in the areas of people, planet, and products since 2020 [2][3] Group 1: Sustainability Commitment - The company emphasizes that sustainability is a fundamental part of its mission to create the healthiest family on earth [2] - USANA's sustainability achievements include significant advancements in employee engagement, leadership diversity, and energy use [6] Group 2: Stakeholder Assessment - In 2020, USANA initiated a formal stakeholder assessment to evaluate its sustainability performance and identify key issues [3] Group 3: Achievements and Initiatives - Key achievements include 84% engagement in global employee surveys, 51% of leadership positions held by women, and 58% of energy use at its Salt Lake campus sourced from solar and renewable energy [6] - The company diverted 57% of operational waste from landfills and saved the equivalent of 300,319 supplement bottles worth of plastic in 2024 [6] - USANA provided 12.3 million meals through the USANA Foundation and employees completed over 2,690 volunteer hours [6] - The company launched seven new products and invested $11.6 million in research and development [6]

Core Viewpoint - Mobile-health Network Solutions (MNDR) intends to acquire Lifepack, a leading pharmacy and telehealth platform in Indonesia, to expand its presence in the high-growth Indonesian healthcare market [1][2][5]. Group 1: Acquisition Details - The acquisition of Lifepack is valued at up to US$7.2 million, contingent upon Lifepack achieving its revenue target for 2025 [5]. - The consideration will be satisfied through the issuance of up to 875,000 new MNDR Class A Ordinary Shares at an issue price of US$8 per share, along with a non-refundable cash payment of US$0.2 million [5][7]. - The US$8 per share issue price represents a substantial premium to MNDR's current share price of approximately US$1.42 as of April 29, 2025, indicating the perceived value of the acquisition [5]. Group 2: Strategic Importance - The acquisition aligns with Indonesia's primary care needs and complements MNDR's telehealth expertise, aiming to serve 280 million people across 17,000 islands [2][3]. - Lifepack's platform is compliant with BPOM regulations and is positioned to lead the Indonesian digital pharmacy market, enhancing healthcare access, especially in remote areas [4][3]. - The partnership aims to create a transformative online-to-offline (O2O) healthcare platform that addresses the unique needs of Indonesia's diverse population [3][4]. Group 3: Lifepack's Operations - Lifepack operates a hybrid model delivering BPOM-licensed prescription drugs, over-the-counter medications, supplements, and medical equipment through both online and offline channels [3][9]. - The platform offers consultations with healthcare professionals via its mobile app, website, and social media, supported by an expanding warehouse network [3][9]. - Lifepack focuses on chronic disease management and preventive care, addressing the growing demand for affordable medical services in Indonesia [3][4].